T he ability of dibucain, a local anesthetic, to enhance the cytotoxicity of and the repair of potentially lethal damage induced by pepleomycin or X-rays has been studied in exponential and plateau phase cultures of Chinese hamster cells. No enhancement of X-ray cytotoxicity or inhibition of repair from X-ray injury was observed, but dibucain produced very significant enhancement of pepleomycin effectiveness. In both cases the effects induced were larger in the exponentially growing cells than in the plateau phase cells. Greater than 20-fold increases in the cytotoxic effectiveness of pepleomycin, and greater than 10-fold differences in survival after the cells had been allowed to repair the potentially lethal damage induced by pepleomycin were observed when the cells were treated with dibucain. The possible mechanisms underlying this enhance ment are discussed.
INTRODUCTION
Bleomycin is a glycopeptide antibiotic which is used widely in the treatment of cancer. The cytotoxic effects of this agent have been reported to be enhanced by local anesthetics,') which act on the cell membrane.2, 3) It has been suggested that these membrane effects produce enhancement of bleomycin cytotoxicity by altering the uptake and efflux of the drug. Re cently, pepleomycin (3-[(S)-1'-phenylethylamina] -propylaminobleomycin) has been reported to be twice as effective as bleomycin,a) and to show similar enhanced toxicity in exponentially growing cells in the presence of the local anesthetic, lidocain.5) The present report concerns the ability of another local anesthetic, dibucain, to enhance the cytotoxic effects of pepleo mycin in both exponential and plateau phase cells and to inhibit the repair of potentially lethal damage induced by pepleomycin, and compares these results to the effects of dibucain in an X-ray induced injury system.
MATERIALS AND METHODS

Cell Culture
The Chinese hamster V79-1 cell line was used in these studies and grown in modified Eagle's Medium') supplemented with 15% newborn calf serum (EM 15) . For the analysis of exponentially growing cells, appropriate numbers of cells were plated in 6 cm petri dishes and incubated overnight under standard conditions. This procedure assured a reproducible asynchronous distribution of cells throughout the cell cycle and produced microcolonies, consisting of an average of three cells, at the time of treatment.
Five to six days after plating into 6 cm petri dishes, these cells reaches confluency and were used for the analysis of plateau phase cells. Immediately after treatment, the cells were washed, trypsinized, counted, diluted and plated. In the analyses of potentially lethal damage (PLD) repair, the plateau phase cultures were washed and refed immediately after treatment, but the subculturing was delayed up to 8 hours after treatment. The increase in survival associated with the delay of subculture is equated with the repair of PLD.
Ten to fourteen days after plating, the plates were stained with methylene blue and the colonies were counted. The surviving fraction is equal to the colony-forming efficiency of the treated cells divided by that of the control cultures.
Drug Treatment and X-ray Exposure
Pepleomycin was dissolved in EM 15 immediately before use and maintained on ice. Prior to addition to the cultures, the drug was diluted with 37°C medium. All pepleomycin exposures were for 2 hours, a time sufficient to produce exponential survival kinetics.°) Dibucain was dissolved in saline at a concentration of 2 mM, which, when added to the cultures, produced a final concentration of 0.2 mM, which was used throughout these experi ments. Following drug treatment, the cells were washed with EM 15 and refed.
X-rays were delivered on a 250 kV unit operated at 20 mA. The dose rate, after filtration through 0.5 mm Cu and 1.0 mm Al, averaged 95.1 rad/minute at the 50 cm target to sample distance.
RESULTS
Drug Effects on Exponentially Growing Cells
The effects of time of exposure to fixed concentrations of pepleomycin (closed circles), dibucain (closed triangles) or both drugs (closed squares) are summarized in Figure 1 . Dibucain alone produced no detectable cytotoxicity over the time period studied, but greatly enhanced the cytotoxicity of pepleomycin. As an example, exposure to both drugs for 1 hour reduced survival to less than 0.02%, while a similar exposure to pepleomycin alone allowed for 40% survival. We conclude that nontoxic concentrations of dibucain can significantly enhance the cytotoxic effects of pepleomycin.
In Figure 2 are plotted the survival curves for exponentially growing cells exposed to graded concentrations of pepleomycin for 2 hours, with (closed triangles) and without (closed circles) simultaneous exposure to 0.2 mM dibucain. The pepleomycin alone curve confirms our earlier observations°). As was the case in the exposure time study (Figure 1 ), dibucain significantly enhanced the cytotoxic effects of pepleomycin throughout the dose range studied ( Figure 2 ). In the absence of dibucain, it required 123 pg/ml and 277 µg/ml to reduce survival to 10 and 1%, respectively. Addition of 0.2 mM dibucain to the medium reduced the pepleo mycin concentrations required to produce these same levels of survival to 6 and 12.3 µg/ml, i.e., the cytotoxicity of pepleomycin was enhanced more than 20-fold. Although repair of potentially lethal damage (PLDR) is more difficult to demonstrate in actively growing cells than in plateau phase cultures, treatments which enhance the expression of injury in these cells are operationally defined as PLDR inhibitors.7, ') Our method for inhibiting PLDR in these exponentially growing cells consisted of treatment with hypertonic saline (0.5 M) and trypsinization immediately after treatment.9)
As controls for these studies, we investigated the effects of trypsinization (open circles) or hypertonic saline (closed triangles) on the survival of cells exposed to pepleomycin ( Figure 3) ; i.e., treatment with hypertonic solution was performed using PBS solution (0.5 M NaCl), and trypsinization was carried out just before final incubation. Both treatments enhanced the cyto toxic effects of pepleomycin compared to the survival levels observed with pre-plated cells ( Figure 2 ). Figure 4 represents the cell survival expected after correc tion for dibucain induced cytotoxicity. Two points are apparent from these studies; dibucain exposure produced significant inhibition of repair from pepleomycin induced PLD, and, further, prolonged treatment of pepleomycin exposed cells, which are trying to repair PLD, produces an enhanced cytotoxic effect (Figure 4) . Fig. 4 . The modification by dibucain on PLD repair of exponentially growing cells exposed to pepleomycin. The cells treated with pepleomycin of 100 µg/ml or pepleomycin for 2 hours and dibucain of 0.2 mM was incubated for various hours and followed by hypertonic treatment for 20 minutes or trypsini zation just before final incubation. z,: surviving fractions of cells treated with dibucain only for various hours. o: surviving fractions of cells exposed to pepleomycin alone for 2 hours, then incubated for various hours and followed by hypertonic treatment.
•: surviving fractions of cells treated with pepleomycin for 2 hours, then incubated with dibucain for various hours and followed by subculturing with trypsinization. o: surviving fractions of cells exposed to pepleomycin, then incubated with dibucain for various hours and added hyper tonic solution.
Drug Effects in Plateau Phase Cells Figure 5 is a plot of the survival of plateau phase cells exposed to graded concentrations of pepleomycin in the presence (closed circles) or absence (open circles) or dibucain. While all of the data points for combined drug treatment fall below those for pepleomycin treatment alone, none of the individual survival levels could be shown to be significantly reduced. A similar lack of potentiation was observed in plateau phase cultures exposed to 100 µg/ml of pepleomycin for varying periods of time in the presence and absence of dibucain. Both of these results contrast sharply with the results obtained with exponentially growing cells (Figures 1 and 2) . •: surviving fractions of cells exposed to pepleomycin for 2 hours and incubated with dibucain for various hours. Figure 6 summarizes our studies on the ability of dibucain to inhibit pepleomycin induced PLDR in plateau phase cultures. Expsoure of these cultures to dibucain produced detectable cytotoxicity with time (closed triangles), which is taken into account below . Repair of PLD in these cells is readily demonstrable (open circles) by letting time elapse before the plateau phase cultures are subcultured (Figure 6 ). If, during this period allowed for PLDR, dibucain is in cluded in the medium, PLDR inhibition and dibucain induced cytotoxicity are again observed (Figure 6) , as was the case for exponentially growing cells (Figure 4) . The dotted line in Figure  6 represents the expected survival after correction for dibucain induced cytotoxicity .
Effect of Dibucain on X-ray PLDR Figure 7 contains the survival curves for exponentially growing cells exposed to X-rays alone (open circles) or to X-rays followed by a 2 hours expoure to dibucain. Addition of dibucain to the treatment produces a consistent but very small enhancement of X-ray induced cytotoxicity. Figure 8 is a plot of the survival of plateau phase cells exposed to dibucain alone (open triangles), 1500 rads followed by culture in EM 15 for varying periods before hypertonic treat ment (open circles) or 1500 rads followed by incubation in dibucain containing medium for varying periods before hypertonic treatment (closed circles). The dashed lines represents the survival expected after correction for dibucain induced cytotoxicity. Although the enhanced cytotoxicity of dibucain for cells undergoing PLDR parallels that observed with pepleomycin ( Figures 4 and 6) , dibucain does not appear to inhibit X-ray induced PLDR (Figure 8 ). This contrasts sharply with the ability of this agent to inhibit pepleomycin induced PLDR ( Figures  4 and 6) . •: surviving fractions of cells treated with dibucain for various hours after X-irradiation.
DISCUSSION
Dibucain has been shown above to enhance the cytotoxic effects of and to inhibit the repair of PLD induced by pepleomycin. Further both of these effects are far larger in exponen tially growing cells than in plateau phase cells. Mizuno et al.6) reported that a different local anesthetic , lidocain, enhanced pepleomycin effectiveness at 410C, but, in contrast to our results, they observed no enhancement at 37°C . Tsuruo et al.10) observed an enhanced effectiveness of vincristine in vincristine-resistant leu kemia cells when the calcium channel blocker, verapamil , was added to the medium. This enhancement was attributed to the ability of this agent to interfere with the active efflux of the drug. Mizuno et al.") demonstrated a similar enhancement of bleomycin cytotoxicity by verapamil and by elevation of the CaCl2 concentration in the medium . Since ruthenium red, a calcium transport inhibitor, reversed the enhancing effects of CaC12 , these authors argued that the enhancement was mediated via elevation of intracellular calcium levels . They also concluded that the enhancing effects of dibucain were not associated with an increase in 3H -pepleomycin absorption , but it remains possible that this factor may vary depending on the membrane characteristics of the specific cell line studied . Uehara et al.12) reported that cobalt ions, but not copper, zinc , or ion (++ or +++) ions enhanced the uptake of pepleomycin in L5178Y mouse leukemia cells with the drug being transported as the cobalt ion complex and this proposal has been supported by other investi gators. [13] [14] [15] [16] Further study of dibucain enhancement should include analysis of the cellular pharmacokinetics of this complex, which may yield different results than were obtained with 3H -pepleomycin .ii)
From the data presented above, it is not possible to reach definitive conclusions regarding the mechanism of dibucain enhancement of pepleomycin effectiveness. Since pepleomycin alone is equally effective in exponentially growing and plateau phase cells, it would not appear that the culture conditions of the cells alters the amount of drug absorbed, yet the enhancing effects of dibucain are far more pronounced in exponentially growing cells (Figure 4 ) than in plateau phase cells (Figure 6 ). Further, dibucain does not alter X-ray induced PLDR, suggesting that the target for pepleomycin and X-ray PLDR inhibition is not the same.
Whatever, the mechanism underlying this enhancement of pepleomycin effectiveness , dibucain might prove to be an effective means of increasing the anti-tumor effectiveness of pepleomycin in vivo, and studies are in progress to answer this question.
